St. Jude, Guidant Swap Distribution Rights Strategies With Investors
This article was originally published in The Gray Sheet
Medical device start-ups seeking equity investments from larger firms should avoid signing over total distribution rights to their potential partners, according to Guidant
You may also be interested in...
Boston Scientific is extracting a painful lesson from its failed business relationship with former stent partner Medinol: never delegate manufacturing and R&D authority to another firm
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.